Leading a team of researchers providing strategic health economic and outcomes research (HEOR) consulting services to assist healthcare companies achieve positive reimbursement decisions in North American and European markets through all stages of a product life cycle. I specialize in health economic modelling, including cost-effectiveness analysis (CEA/CUA), budget impact model (BIA/BIM), and comparative effectiveness (CE) analysis, including indirect treatment comparison (ITC), simulated treatment comparison (STC) and matched adjusted indirect treatment comparison (MAIC) to support health technology assessment (HTA) submissions. Experiences in oncology, chronic and orphan diseases. Submissions made successfully to the National Institute for Health and Care Excellence (NICE), Canadian Agency for Drugs and Technologies in Health (CADTH), and US insurers. Proficient in all relevant programming languages regularly employed by a health economist, including VBA, R, Stata, and the whole of the Microsoft Suite.
Listed skills include Research, Leadership, Digital Marketing, Public Speaking, and 30 others.